Arnaud Foussat

Arnaud Foussat's work experience includes:

- Operating Partner at Adbio Partners since July 2017.

- Chief Executive Officer at Alderaan Biotechnology since June 2019.

- Chief Operating Officer at Alderaan Biotechnology from July 2017 to June 2019.

- Chief Executive Officer at Yukin Therapeutics since May 2019.

- Chief Operating Officer at Yukin Therapeutics from June 2018 to May 2019.

- SVP Corporate Development & Alliance Management at TxCell from October 2016 to March 2017.

- Chief Scientific Officer at TxCell from April 2015 to October 2016.

- VP Research & New Products at TxCell from September 2012 to April 2015.

- Director of Research & Development at TxCell from November 2005 to August 2012.

- Head of Non-Clinical Research at TxCell from September 2004 to 2005.

Arnaud Foussat completed their Master's Degree in Immunology at Institut Pasteur from 1995 to 1996. Arnaud then pursued their higher education at Université Paris Cité, where they obtained a PhD in Immunology from 1996 to 2000. No other information is available regarding their education history beyond these mentioned experiences.